0069-0106Level 3
ELELYSO (Taliglucerase alfa)
**Product type:** Human Prescription Drug
**Active ingredient:** TALIGLUCERASE ALFA
**Strength:** 200 U/5mL
**Dosage form:** Injection, Powder, Lyophilized, For Solution
**Route:** Intravenous
**Labeler:** Pfizer Laboratories Div Pfizer Inc
**Marketing category:** BLA (BLA022458)
**Pharmacologic class:** Glucosylceramidase [CS], Hydrolytic Lysosomal Glucocerebroside-specific Enzyme [EPC]
GET
/api/v1/systems/ndc_fda/nodes/0069-0106Hierarchy Explorer
Loading...
Cross-system equivalences0
No cross-system equivalences mapped for this node.